Anti-myostatin

Clinical trials for Anti-myostatin explained in plain language.

Never miss a new study

Get alerted when new Anti-myostatin trials appear

Sign up with your email to follow new studies for Anti-myostatin, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1 Completed 1

New drug hopes to boost muscle power in babies with SMA

Disease control Recruiting now

This study tests a drug called apitegromab in children under 2 years old who have spinal muscular atrophy (SMA), a genetic condition that causes muscle weakness. The drug works by blocking a protein that limits muscle growth. Researchers want to see if adding apitegromab to stand…

Matched conditions: ANTI-MYOSTATIN

Phase 2 • Sponsor: Scholar Rock, Inc. • Aim: Disease control

Last updated Jun 27, 2026 12:28 UTC

Anti-myostatin

Get alerted when new Anti-myostatin trials appear

New drug hopes to boost muscle power in babies with SMA